Obstructive Sleep Apnea

Incannex Meets with FDA in Pre-IND Meeting for Sleep Apnea Drug Candidate

Incannex characterized the pre-investigational new drug application (pre-IND) meeting about IHL-42X as “highly constructive.”

Obstructive Sleep Apnea

Axsome Completes US Acquisition of Sunosi

'The Sunosi acquisition marks the transformation of Axsome into a commercial neuroscience company and reflects our commitment to the millions of people living with serious neurologic and psychiatric conditions.'

Obstructive Sleep Apnea

Philips Ups Staffing Related to CPAP Recall

Management responsibility and oversight have been strengthened with organizational changes implemented in Philips Respironics.

Inspire Trialed in Children with Down Syndrome and Sleep Apnea

Apr 27, 2022 | Age, Neurostimulators, Obstructive Sleep Apnea

Children with Down syndrome and sleep apnea are more likely to experience aggressive behavior, brain fogging, and a loss of nearly 10 points in IQ compared to those without.

Underdiagnosis of Sleep Apnea Is a Problem That Technology Can Help Fix

Apr 25, 2022 | Home Apnea Testing, Obstructive Sleep Apnea

Advances in home sleep testing may chip away at the number of people who remain undiagnosed while capturing a more accurate calculation of the apnea hypopnea index.

Risky Driving Behaviors Increase as Common Sleep Disorder Worsens

Apr 20, 2022 | Curated, Obstructive Sleep Apnea

Diagnosing and treating sleep apnea may make driving safer for older adults.

Is a Drug for Sleep Apnea on the Horizon?

Apr 20, 2022 | Curated, Obstructive Sleep Apnea

Researchers think they’ve found a drug that might ease sleep apnea.

REM-Obstructive Sleep Apnea Associated with Early Signs of Atherosclerosis

Apr 14, 2022 | Curated, Obstructive Sleep Apnea

A new investigation found that rapid eye movement obstructive sleep apnea (REM-OSA) was associated with early signs of atherosclerosis, though the association remained unclear.

Sulthiame Lowers AHI At Least 50% in Trial

Apr 12, 2022 | Curated, Emerging Compounds, Obstructive Sleep Apnea

Sulthiame, a carbonic anhydrase inhibitor, lowered obstructive sleep apnea by more than 20 events/hour, a notable decline for a drug trial.

Sleep-Related Hypoxia Tied to Worse COVID Outcomes

Apr 12, 2022 | Hypoxia, Obstructive Sleep Apnea

While those with sleep apnea did have more severe outcomes with COVID-19, they were not at a higher risk for contracting the virus.

Is There a Clinical Role for Sleep Apnea Apps?

Apr 7, 2022 | Curated, Obstructive Sleep Apnea

There has been increasing interest in the use of sleep apnea apps to aid in the detection and treatment of OSA.

Axsome Therapeutics to Acquire Sunosi from Jazz Pharmaceuticals

Mar 29, 2022 | Narcolepsy, Obstructive Sleep Apnea, Prescription Drugs

The acquisition of Sunosi adds a high-potential commercial asset to Axsome’s late-stage neuroscience portfolio.

New Approach to Describing Sleep Architecture May Help Direct Therapy for Sleep Disorders

Mar 28, 2022 | AI & Machine Learning, Circadian & Sleep Biomarkers, Home Apnea Testing, Impact During Wake, Insomnia, Obstructive Sleep Apnea

Magdy Younes and associates have revealed new insights into clinical symptoms of sleep disorders found in sleep architecture.

Panthera Acquires Pediatric Oral Appliance

Mar 11, 2022 | Age, Obstructive Sleep Apnea, Oral Appliances

Previously named SomNyx, the appliance will be rebranded as D-SAD|Myo within Panthera Dental’s digital sleep appliance range.

Study: Sleep Apnea Accelerates Aging

Mar 10, 2022 | Curated, Obstructive Sleep Apnea, Sleep & the Body

Researchers from the University of Missouri School of Medicine have found that untreated sleep apnea accelerates the biological aging process and that appropriate treatment can slow or possibly reverse the trend.

SomnoMed Introduces Smart Oral Appliance That Measures Efficacy & Adherence

Mar 9, 2022 | CPAP Data, Emerging Technology, Obstructive Sleep Apnea, Oral Appliances

Rest Assure is a smart oral appliance that transfers efficacy and adherence data to cloud-based servers, allowing physicians and dentists to see the results.